Mintz advised Relation, an industry leader in deploying computation and experimentation to drug discovery, on an equity investment of $15 million from GSK in connection with two simultaneous strategic collaborations with GSK, a global biopharma company. The collaborations are aimed at advancing the development of novel therapeutics for fibrotic diseases and osteoarthritis – conditions which affect millions worldwide and which currently have few treatments addressing their root causes. 

Under the terms of the collaboration agreements, Relation will receive an upfront payment from GSK of $45 million, inclusive of the equity investment. Relation will also be eligible for success-based collaboration payments of up to $63 million, as well as potential preclinical, development, and commercial milestone payments averaging $200 million per target, and tiered royalties on net sales of products. 

The Mintz team was led by Member Lewis Geffen and Associate Sarah Palmer, who have represented Relation since incorporation. 

Relation is a platform biotechnology company developing medicines for diseases with significant unmet need. Relation’s Lab-in-the-Loop platform combines human genetics, single-cell multi-omics directly from human tissue, functional assays, and machine learning to discover novel disease interventions. The company has programs across metabolic and immune diseases. To date, the company has raised over $80 million from leading investors, including DCVC, Magnetic, GSK, NVIDIA NVentures, Hitachi Ventures, Khosla and Deerfield. 

Additional information about the collaborations is available here.

With over 200+ industry-focused practitioners worldwide, Mintz’s Life Sciences team represents life sciences companies across the industry spectrum: therapeutics, vaccines, medical devices, research tools, diagnostics, as well as investment banks, venture capital firms, and other investors.  The firm’s work for these clients encompasses intellectual property, corporate, regulatory, litigation, employment, real estate, and other matters.  Mintz is embedded in the global life sciences ecosystem, providing industry leaders with practical solutions to business-critical challenges and helping them to navigate the complex regulatory and global business environment in which they operate to successfully achieve their goals.

About Mintz

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.